Matthew D Dallas - Net Worth and Insider Trading
Matthew D Dallas Net Worth
The estimated net worth of Matthew D Dallas is at least $2 Million dollars as of 2024-11-13. Matthew D Dallas is the CFO of CoLucid Pharmaceuticals Inc and owns about 40,128 shares of CoLucid Pharmaceuticals Inc (CLCD) stock worth over $2 Million. Matthew D Dallas is also the VP, Finance of AVEO Pharmaceuticals Inc and owns about 1,959 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $29,385. Details can be seen in Matthew D Dallas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew D Dallas has not made any transactions after 2017-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew D Dallas
Matthew D Dallas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew D Dallas owns 3 companies in total, including Harvard Apparatus Regenerative Technology Inc (HRGN) , AVEO Pharmaceuticals Inc (AVEO) , and CoLucid Pharmaceuticals Inc (CLCD) .
Click here to see the complete history of Matthew D Dallas’s form 4 insider trades.
Insider Ownership Summary of Matthew D Dallas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRGN | Harvard Apparatus Regenerative Technology Inc | 2018-11-06 | director |
| AVEO | AVEO Pharmaceuticals Inc | 2017-06-01 | Chief Financial Officer |
| CLCD | CoLucid Pharmaceuticals Inc | 2017-03-01 | Chief Financial Officer |
Matthew D Dallas Latest Holdings Summary
Matthew D Dallas currently owns a total of 2 stocks. Among these stocks, Matthew D Dallas owns 40,128 shares of CoLucid Pharmaceuticals Inc (CLCD) as of January 3, 2017, with a value of $2 Million and a weighting of 98.45%. Matthew D Dallas also owns 1,959 shares of AVEO Pharmaceuticals Inc (AVEO) as of July 1, 2014, with a value of $29,385 and a weighting of 1.55%.
Latest Holdings of Matthew D Dallas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLCD | CoLucid Pharmaceuticals Inc | 2017-01-03 | 40,128 | 46.53 | 1,866,955 |
| AVEO | AVEO Pharmaceuticals Inc | 2014-07-01 | 1,959 | 15.00 | 29,385 |
Holding Weightings of Matthew D Dallas
Matthew D Dallas Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew D Dallas has made a total of 0 transactions in CoLucid Pharmaceuticals Inc (CLCD) over the past 5 years. The most-recent trade in CoLucid Pharmaceuticals Inc is the sale of 1,473 shares on January 3, 2017, which brought Matthew D Dallas around $53,396.
According to the SEC Form 4 filings, Matthew D Dallas has made a total of 0 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years. The most-recent trade in AVEO Pharmaceuticals Inc is the sale of 0 shares on July 1, 2014, which brought Matthew D Dallas around $0.
Insider Trading History of Matthew D Dallas
- 1
Matthew D Dallas Trading Performance
Matthew D Dallas Ownership Network
Ownership Network List of Matthew D Dallas
Ownership Network Relation of Matthew D Dallas
Matthew D Dallas Owned Company Details
What does Harvard Apparatus Regenerative Technology Inc do?
Who are the key executives at Harvard Apparatus Regenerative Technology Inc?
Matthew D Dallas is the director of Harvard Apparatus Regenerative Technology Inc. Other key executives at Harvard Apparatus Regenerative Technology Inc include 10 percent owner Dst Capital Llc , President Hong Yu , and Chief Financial Officer Damasio Joseph Luis Jr .
Harvard Apparatus Regenerative Technology Inc (HRGN) Insider Trades Summary
Over the past 18 months, Matthew D Dallas made no insider transaction in Harvard Apparatus Regenerative Technology Inc (HRGN). Other recent insider transactions involving Harvard Apparatus Regenerative Technology Inc (HRGN) include a net purchase of 22,001 shares made by Junli He , and a net purchase of 6,864 shares made by James E. Shmerling .
In summary, during the past 3 months, insiders sold 0 shares of Harvard Apparatus Regenerative Technology Inc (HRGN) in total and bought 5,101 shares, with a net purchase of 5,101 shares. During the past 18 months, 0 shares of Harvard Apparatus Regenerative Technology Inc (HRGN) were sold and 28,865 shares were bought by its insiders, resulting in a net purchase of 28,865 shares.
Harvard Apparatus Regenerative Technology Inc (HRGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Harvard Apparatus Regenerative Technology Inc Insider Transactions
Matthew D Dallas Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew D Dallas. You might contact Matthew D Dallas via mailing address: Aveo Pharmaceuticals, Inc., 650 East Kendall Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
